KLK3 and prostate cancer: Incorporating Digital Rectal Examination (DRE) alongside Prostate-Specific Antigen (PSA) screening has been shown to offer significant economic benefits, owing to its heightened sensitivity, specificity, and diagnostic accuracy in detecting prostate cancer [21].